Biosimilars Innovation: The Physician’s Role in Bringing the Best Insulin Options to Patients Living with Diabetes – Mainpro+

Upon completion of this program, participants will be able to:

• Describe the difference between biosimilars and generic agents.
• Discuss the safety, efficacy, clinical role and use of biosimilar insulins to treat to target with patients.
• Apply knowledge of the pharmacokinetics and clinical considerations of biosimilar insulins.
• Prescribe biosimilar insulins for the appropriate patients.